New potent antagonists of leukotrienes C4 and D4. 1. Synthesis and structure-activity relationships. 1988

H Nakai, and M Konno, and S Kosuge, and S Sakuyama, and M Toda, and Y Arai, and T Obata, and N Katsube, and T Miyamoto, and T Okegawa
Research Institute, Ono Pharmaceutical Co., Ltd., Osaka, Japan.

(p-Amylcinnamoyl)anthranilic acid (3a) had moderate antagonist activities against LTD4-induced smooth muscle contraction on guinea pig ileum and LTC4-induced bronchoconstriction in anesthetized guinea pigs. Modifications were made in the hydrophobic part (cinnamoyl moiety) and the hydrophilic part (anthranilate moiety) of 3a. A series of 8-(benzoylamino)-2-tetrazol-5-yl-1,4-benzodioxans and 8-(benzoylamino)-2-tetrazol-5-yl-4-oxo-4H-1-benzopyrans were revealed to be potent antagonists of leukotrienes C4 and D4. Among both series, ONO-RS-347 (18k) and ONO-RS-411 (19h) were the most potent and orally active antagonists, respectively. Structure-activity relationships are discussed.

UI MeSH Term Description Entries
D007082 Ileum The distal and narrowest portion of the SMALL INTESTINE, between the JEJUNUM and the ILEOCECAL VALVE of the LARGE INTESTINE.
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D001993 Bronchodilator Agents Agents that cause an increase in the expansion of a bronchus or bronchial tubes. Bronchial-Dilating Agents,Bronchodilator,Bronchodilator Agent,Broncholytic Agent,Bronchodilator Effect,Bronchodilator Effects,Bronchodilators,Broncholytic Agents,Broncholytic Effect,Broncholytic Effects,Agent, Bronchodilator,Agent, Broncholytic,Agents, Bronchial-Dilating,Agents, Bronchodilator,Agents, Broncholytic,Bronchial Dilating Agents,Effect, Bronchodilator,Effect, Broncholytic,Effects, Bronchodilator,Effects, Broncholytic
D002934 Cinnamates Derivatives of cinnamic acid (the structural formula: phenyl-HC Cinnamate
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass
D013189 SRS-A A group of LEUKOTRIENES; (LTC4; LTD4; and LTE4) that is the major mediator of BRONCHOCONSTRICTION; HYPERSENSITIVITY; and other allergic reactions. Earlier studies described a "slow-reacting substance of ANAPHYLAXIS" released from lung by cobra venom or after anaphylactic shock. The relationship between SRS-A leukotrienes was established by UV which showed the presence of the conjugated triene. (From Merck Index, 11th ed) Slow Reacting Substance of Anaphylaxis
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

H Nakai, and M Konno, and S Kosuge, and S Sakuyama, and M Toda, and Y Arai, and T Obata, and N Katsube, and T Miyamoto, and T Okegawa
December 1989, The Journal of investigative dermatology,
H Nakai, and M Konno, and S Kosuge, and S Sakuyama, and M Toda, and Y Arai, and T Obata, and N Katsube, and T Miyamoto, and T Okegawa
November 1980, Acta physiologica Scandinavica,
H Nakai, and M Konno, and S Kosuge, and S Sakuyama, and M Toda, and Y Arai, and T Obata, and N Katsube, and T Miyamoto, and T Okegawa
October 1987, Journal of pharmaceutical sciences,
H Nakai, and M Konno, and S Kosuge, and S Sakuyama, and M Toda, and Y Arai, and T Obata, and N Katsube, and T Miyamoto, and T Okegawa
April 1983, Canadian journal of physiology and pharmacology,
H Nakai, and M Konno, and S Kosuge, and S Sakuyama, and M Toda, and Y Arai, and T Obata, and N Katsube, and T Miyamoto, and T Okegawa
August 2009, Bioorganic & medicinal chemistry letters,
H Nakai, and M Konno, and S Kosuge, and S Sakuyama, and M Toda, and Y Arai, and T Obata, and N Katsube, and T Miyamoto, and T Okegawa
January 2002, Bioorganic & medicinal chemistry letters,
H Nakai, and M Konno, and S Kosuge, and S Sakuyama, and M Toda, and Y Arai, and T Obata, and N Katsube, and T Miyamoto, and T Okegawa
June 2013, Bioorganic & medicinal chemistry letters,
H Nakai, and M Konno, and S Kosuge, and S Sakuyama, and M Toda, and Y Arai, and T Obata, and N Katsube, and T Miyamoto, and T Okegawa
April 1985, Prostaglandins,
H Nakai, and M Konno, and S Kosuge, and S Sakuyama, and M Toda, and Y Arai, and T Obata, and N Katsube, and T Miyamoto, and T Okegawa
February 2005, Bioorganic & medicinal chemistry letters,
H Nakai, and M Konno, and S Kosuge, and S Sakuyama, and M Toda, and Y Arai, and T Obata, and N Katsube, and T Miyamoto, and T Okegawa
April 2001, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!